ALZN NASDAQ
Alzamend Neuro Inc
1W: -13.1%
1M: -34.7%
3M: -15.7%
YTD: -40.5%
1Y: -54.6%
3Y: -99.6%
5Y: -100.0%
$1.13
-0.01 (-0.88%)
Weekly Expected Move ±14.2%
$1
$1
$1
$1
$1
Credit Risk of going bust: not rated Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
Not rated: no debt. Altman Z'' -27.54.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
9 relationships9
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2023-09-08
Earliest Filing
2026-03-06
Latest Filing
partner: 3
investor: 3
target: 2
customer: 1
Counterparties (Filed by ALZN)
9 relationshipsCompanies named in ALZN's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Ascendiant Capital Markets, LLC | — | partner | Sales agent for the At-the-Market Issuance Sales Agreement | 2026-03-06 | View |
| Alzamend Neuro, Inc. | ALZN | target | Company issuing Series C Convertible Preferred Stock and exchanging Subject Shares | 2025-02-28 | View |
| Orchid Finance LLC | — | investor | Purchaser acquiring Preferred Shares and exchanging Subject Shares | 2025-02-28 | View |
| Alzamend Neuro, Inc. | ALZN | target | Company issuing Preferred Shares and warrants to Purchaser | 2024-05-09 | View |
| Orchid Finance LLC | — | investor | Purchaser acquiring Preferred Shares and warrants from the Company | 2024-05-09 | View |
| Alzamend Neuro, Inc. | ALZN | customer | Company issuing the note and receiving the loan | 2024-04-30 | View |
| Ault Lending, LLC | — | partner | Entity providing a guarantee for the obligations | 2024-04-30 | View |
| Ault Lending, LLC | — | investor | Purchased Series B convertible preferred stock and warrants for $2.0 million | 2024-03-29 | View |
| Ascendiant Capital Markets, LLC | — | partner | Agent for the at-the-market issuance of common stock | 2023-09-08 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-29 | Regulation FD; Exhibits | View | |
| 2026-08-03 | Material Agreement; Delisting Notice; Unregistered Equity Sales; Bylaws Amendment; Exhibits | Agreement | View |
| 2026-07-21 | Other Events; Exhibits | View | |
| 2026-04-17 | Shareholder Vote; Exhibits | View | |
| 2026-03-20 | Delisting Notice; Exhibits | View | |
| 2026-03-06 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-11-18 | Other Events; Financial Statements and Exhibits | View | |
| 2025-10-14 | Amendments to Articles of Incorporation or Bylaws; Financial Statements and Exhibits | View | |
| 2025-10-09 | Unregistered Sales of Equity Securities; Financial Statements and Exhibits | View | |
| 2025-09-25 | Unregistered Sales of Equity Securities; Financial Statements and Exhibits | View | |
| 2025-08-01 | Unregistered Sales of Equity Securities; Financial Statements and Exhibits | View | |
| 2025-07-23 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-07-09 | Amendments to Articles of Incorporation or Bylaws; Financial Statements and Exhibits | View | |
| 2025-05-08 | Amendments to Articles of Incorporation or Bylaws; Regulation FD Disclosure; Financial Statements an | View | |
| 2025-04-25 | Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits | View | |
| 2025-03-03 | Amendments to Articles of Incorporation or Bylaws; Financial Statements and Exhibits | View | |
| 2025-02-28 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
| 2024-12-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-10-15 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2024-10-03 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR